Cellular Immune Response Evaluation in Nepalese Patients with Cutaneous Leishmaniasis

Authors

  • Srijan Shrestha Infectious and Viral Disease Research Laboratory (IVDRL), Central Department of Biotechnology, Tribhuvan University, Kirtipur, Kathmandu
  • Sabita Prajapati Infectious and Viral Disease Research Laboratory (IVDRL), Central Department of Biotechnology, Tribhuvan University, Kirtipur, Kathmandu / Molecular Biotechnology Laboratory, School of Biotechnology, Institute of Agricultural Technology, Suranaree University of Technology, Nakhon Ratchasima, Thailand
  • Jivan Shakya Mycobacterial Research Laboratories, The Leprosy Mission Nepal, Lalitpur / Institute for Research in Science and Technology, Lalitpur
  • Ram Prasad Aganja Nirvana Biotech, Imadol, Lalitpur
  • Binod Manandhar Clark Atlanta University, Atlanta, Georgia
  • William G. Telford National Cancer Institute, National Institute of Health Science, Maryland
  • Paul K. Wallace Roswell Park Comprehensive Cancer Center, Buffalo, New York / SciGro Inc Sedona, Arizona
  • Pragya Gautam Ghimire Nepalgunj Medical College and Teaching hospital, Banke
  • Anup Bastola Sukraraj Tropical and Infectious Disease Hospital, Kathmandu
  • Bimal Sharma Chalise Sukraraj Tropical and Infectious Disease Hospital, Kathmandu
  • Krishna Das Manandhar Infectious and Viral Disease Research Laboratory (IVDRL), Central Department of Biotechnology, Tribhuvan University, Kirtipur, Kathmandu https://orcid.org/0000-0002-6798-4935

DOI:

https://doi.org/10.3126/jnba.v7i1.92086

Keywords:

Cutaneous leishmaniasis, CD8⁺ T cells, Immune response, kDNA PCR

Abstract

Cutaneous leishmaniasis (CL) remains a clinically and immunologically heterogeneous disease influenced by parasite species and host immune responses. In this study, seventeen CL cases were assessed through lesion characteristics, histopathological analysis and Kinetoplast DNA (kDNA) nested Polymerase Chain Reaction (PCR)figure. Lesions mainly appeared on exposed body parts, especially the face (64.70%) and most patients had a single lesion. kDNA PCR confirmed CL in 58.82% (n=10) of cases, identifying Leishmania donovani (720 bp) in 5 cases and L. major (560–590 bp) 5 cases as the circulating species. Immunological analysis showed reduction in T-lymphocytes  in CL patients compared to Healthy Controls (HC), largely due to a significant decrease in CD8⁺ T cells (p=0.036), while CD4⁺ T cell levels remained stable. Further stratification based on CL PCR positivity showed that reductions in T-lymphocytes (p=0.045) were confined to patients with confirmed Leishmania infection, again attributed mainly to decreased CD8⁺ T cells (p=0.040). No notable changes were observed in B cells, NK cells, or NKT cells. These findings highlight CL infection positivity status-dependent variations in host immune responses and emphasize the importance of CD8⁺ T-lymphocytes in CL pathogenesis and disease outcome.

Downloads

Download data is not yet available.
Abstract
0
PDF
0

Downloads

Published

2026-03-25

How to Cite

Shrestha, S., Prajapati, S., Shakya, J., Aganja, R. P., Manandhar, B., Telford, W. G., … Manandhar, K. D. (2026). Cellular Immune Response Evaluation in Nepalese Patients with Cutaneous Leishmaniasis. Journal of Nepal Biotechnology Association, 7(1), 63–74. https://doi.org/10.3126/jnba.v7i1.92086

Issue

Section

Research Articles